Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
19.22
+0.35 (1.85%)
Jun 8, 2026, 11:16 AM EDT - Market open
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +82.10% | Jun 2, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +76.90% | Jun 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $31 | Buy | Initiates | $31 | +61.29% | Feb 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +56.09% | Feb 3, 2026 |